Researchers at the Cancer Epigenetics Institute (CEI) at Fox Chase Cancer Center have discovered how to control and stop the amplification of MYC—one of the most commonly altered cancer genes linked to aggressive tumor growth and treatment resistance.
New Findings on Controlling MYC Gene Amplification in Cancer Research
Researchers at the Cancer Epigenetics Institute have found a way to control the amplification of the MYC gene, which is crucial for understanding aggressive tumor growth and treatment resistance. This discovery could have implications for cancer treatment strategies globally, including in Iran. The advancement in cancer research is significant for improving healthcare outcomes.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%